Inna G Ovsyannikova Selected Research

Neutralizing Antibodies

12/2022	Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination.
1/2022	Proteomic assessment of humoral immune responses in smallpox vaccine recipients.
1/2022	Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.
12/2020	Durability of humoral immune responses to rubella following MMR vaccination.
1/2020	Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
1/2019	Current perspectives in assessing humoral immunity after measles vaccination.
1/2018	Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.
10/2017	Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.
1/2017	A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.
1/2017	Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inna G Ovsyannikova Research Topics

Disease

61	Measles 12/2020 - 06/2002
47	Rubella (German Measles) 01/2021 - 05/2003
27	Mumps 01/2022 - 05/2003
20	Smallpox (Variola) 01/2022 - 11/2005
20	Human Influenza (Influenza) 01/2021 - 06/2004
15	Infections 12/2022 - 02/2005
11	Vaccinia 01/2022 - 11/2005
9	Communicable Diseases (Infectious Diseases) 01/2020 - 06/2004
5	Virus Diseases (Viral Diseases) 01/2020 - 06/2002
3	Zika Virus Infection 01/2021 - 01/2018
3	Hepatitis B 05/2009 - 06/2004
2	COVID-19 12/2022 - 10/2020
2	Poxviridae Infections 01/2020 - 01/2016
2	Vaccine-Preventable Diseases 01/2016 - 08/2015
2	Obesity 08/2015 - 02/2014
2	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 08/2010 - 12/2009
1	Microcephaly 01/2021
1	Bites and Stings (Sting) 01/2020
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2019
1	Wilms Tumor (Wilm's Tumor) 01/2018
1	Congenital Abnormalities (Deformity) 01/2018
1	Celiac Disease (Celiac Sprue) 01/2017
1	Hypothyroidism 01/2017
1	Febrile Seizures (Febrile Seizure) 01/2017
1	Cicatrix (Scar) 01/2016

Drug/Important Bio-Agent (IBA)

82	VaccinesIBA 01/2022 - 05/2003
35	CytokinesIBA 01/2022 - 09/2003
26	Neutralizing AntibodiesIBA 12/2022 - 05/2009
18	AntibodiesIBA 01/2019 - 06/2002
17	Immunoglobulin G (IgG)IBA 12/2020 - 06/2002
15	Measles VaccineIBA 01/2019 - 05/2003
15	Interleukin-6 (Interleukin 6)IBA 01/2018 - 09/2003
14	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2022 - 02/2005
14	HLA Antigens (Human Leukocyte Antigens)IBA 10/2011 - 06/2002
12	Interleukin-2 (IL2)IBA 10/2013 - 09/2003
12	Peptides (Polypeptides)IBA 12/2009 - 06/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
10	Interleukin-10 (Interleukin 10)IBA 11/2020 - 11/2006
8	Cytokine Receptors (Cytokine Receptor)IBA 11/2014 - 01/2007
7	Messenger RNA (mRNA)IBA 12/2022 - 11/2012
7	AntigensIBA 12/2022 - 05/2004
7	Antiviral Agents (Antivirals)IBA 01/2018 - 05/2009
6	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2022 - 11/2005
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 09/2008
6	InterferonsIBA 01/2018 - 01/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 09/2003
5	Interleukin-4 (Interleukin 4)IBA 11/2020 - 09/2003
5	EpitopesIBA 03/2012 - 03/2004
4	ImmunosorbentsIBA 01/2020 - 01/2012
4	EnzymesIBA 01/2020 - 01/2012
4	InterleukinsIBA 11/2014 - 01/2007
4	Rubella VaccineIBA 11/2014 - 02/2007
4	HLA-DQB1 antigen (HLA DQB1)IBA 10/2011 - 05/2008
4	Viral VaccinesIBA 01/2011 - 04/2007
3	ProteomeIBA 01/2022 - 03/2015
3	Mumps Vaccine (Vaccine, Mumps)IBA 01/2022 - 05/2005
3	Viral AntigensIBA 11/2014 - 05/2005
3	HLA-B Antigens (HLA-B)IBA 01/2013 - 02/2007
3	HLA-DRB1 Chains (HLA DRB1)IBA 02/2007 - 08/2003
3	Interferon-gamma (Interferon, gamma)IBA 02/2007 - 09/2003
3	HLA-DRB1*03:01 antigenIBA 06/2006 - 03/2004
3	PhosphoproteinsIBA 11/2005 - 08/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2017
2	ChemokinesIBA 01/2022 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
2	Genetic Markers (Genetic Marker)IBA 10/2017 - 04/2007
2	CholesterolIBA 01/2017 - 01/2016
2	LeptinIBA 01/2016 - 02/2014
2	Granzymes (Granzyme)IBA 01/2016 - 12/2013
2	HLA-DPB1 antigen (HLA DPB1)IBA 03/2015 - 02/2010
2	Interleukin-18 (Interleukin 18)IBA 11/2013 - 08/2011
2	HLA-A Antigens (HLA-A)IBA 01/2013 - 12/2005
2	Hemagglutinins (Hemagglutinin)IBA 06/2011 - 11/2005
2	5' Untranslated Regions (5' UTR)IBA 10/2010 - 01/2010
2	Interleukin-12 Subunit p40IBA 04/2010 - 11/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2010 - 02/2010
2	Vitamin A (Retinol)FDA LinkGeneric 02/2010 - 01/2010
2	HLA-A*02:01 antigenIBA 02/2007 - 11/2005
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	ElementsIBA 01/2022
1	InflammasomesIBA 01/2021
1	COVID-19 VaccinesIBA 10/2020
1	LigandsIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Ferritins (Ferritin)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	LipidsIBA 08/2015
1	A-factor (Streptomyces)IBA 08/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2016 - 05/2009